| Citation: |
NAN Zhenhua, PAN Linghui. Mechanism of Ibuprofen Regulating Migration and Invasion of Liver Cancer QGY-7703 Cells Through PI3K/Akt/mTOR Signaling Pathway[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1035-1038. DOI: 10.3971/j.issn.1000-8578.2016.12.005
|
To investigate the mechanism of ibuprofen regulating the migration and invasion of liver cancer QGY-7703 cells via PI3K/Akt/mTOR signaling pathway.
The liver cancer QGY-7703 cells were divided randomly into control group(C group) and experimental group(B group). Then the experimental group was divided into three subgroups cultured by ibuprofen at different concentrations (B1-3 groups). Group B1 was exposed to ibuprofen with the final concentrations of 250 μmol/L, Group B2 with 500 μmol/L ibuprofen, and Group B3 with 1 000 μmol/L ibuprofen. The control group was exposed to normovolemic RPMIl640 nutrient solution. The migration and invasion of cells with diverse incubating time in different groups were determined by Transwell after 24, 48 or 72h. Real-time PCR was used to measure the expression levels of PI3K, PTEN, MMP-9 mRNA; Western blot was used to evaluate the expression levels of PTEN, Akt, p-Akt, mTOR, p-mTOR, MMP-9 protein after being incubated for 48h.
Compared with C group, the abilities of migration and invasion in the B1-3 groups were significantly decreased in concentration- and time-dependent manner(P<0.01). Compared with C group, the expression levels of PTEN mRNA and protein in B1-3 groups were up-regulated in a concentration-dependent manner with statistical differences(P<0.05). Compared with C group, the expression levels of Akt, mTOR protein and PI3K mRNA had no significant difference(P>0.05). Compared with C group, the expression levels of p-Akt, p-mTOR, MMP-9 protein and MMP-9 mRNA were down-regulated in B1-3 groups, with negative correlation with ibuprofen-treated concentration(P<0.05).
Ibuprofen could inhibit the migration and invasion of liver cancer QGY-7703 cells, which might be related to PI3K/Akt/mTOR signal pathway.
| [1] |
Lockwood GF, Albert KS, Gillespie WR, et al. Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships[J].Clin Parmacol Ther, 1983, 34(1): 97-103.
|
| [1] |
Lockwood GF, Albert KS, Gillespie WR, et al. Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships[J]. Clin Parmacol Ther, 1983, 34(1): 97-103.
|
| [2] |
Gunjal PM, Schneider G, Ismail AA, et al. Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy[J]. J Ovarian Res, 2015, 8: 20. doi: 10.1186/s13048-015-0141-7
|
| [2] |
Gunjal PM, Schneider G, Ismail AA, et al. Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy[J]. J Ovarian Res, 2015, 8: 20.
|
| [3] |
祝丽双, 王浩, 陈佳, 等. 布洛芬抑制人NSCLC细胞株NCI-H460 和乳腺癌细胞株SKBR3增殖和转移的机制探讨[J]. 第二军医 大学学报, 2014, 35(12): 1327-32. [Zhu LS, Wang H, Chen J, et al. Ibuprofen suppresses proliferation and metastasis of human nonsmall cell lung cancer cell line NCI-H460 and breast cancer cell line SKBR3[J]. Di Er Jun Yi Da Xue Xue Bao, 2014, 35(12): 1327-32.]
|
| [3] |
祝丽双, 王浩, 陈佳, 等. 布洛芬抑制人NSCLC细胞株NCI-H460 和乳腺癌细胞株SKBR3增殖和转移的机制探讨[J]. 第二军医大学学报, 2014, 35(12): 1327-32. http://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201412008.htm
Zhu LS, Wang H, Chen J, et al. Ibuprofen suppresses proliferation and metastasis of human non-small cell lung cancer cell line NCI-H460 and breast cancer cell line SKBR3[J]. Di Er Jun Yi Da Xue Xue Bao, 2014, 35(12): 1327-32. http://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201412008.htm
|
| [4] |
Dobbin ZC, Landen CN. The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer[J]. Int J Mol Sci, 2013, 14(4): 8213-27.
|
| [4] |
Dobbin ZC, Landen CN. The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer[J]. Int J Mol Sci, 2013, 14(4): 8213-27. doi: 10.3390/ijms14048213
|
| [5] |
Bai H, Li H, Li W, et al. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines[J]. Oncotarget, 2015, 6(28): 25520-32.
|
| [5] |
Bai H, Li H, Li W, et al. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines[J]. Oncotarget, 2015, 6(28): 25520-32. doi: 10.18632/oncotarget
|
| [6] |
Matsuoka T, Yashiro M. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma[J]. Cancers(Basel), 2014, 6(3): 1441-63.
|
| [6] |
Matsuoka T, Yashiro M. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma[J]. Cancers(Basel), 2014, 6(3): 1441-63. http://cn.bing.com/academic/profile?id=1939f90241ff0f6b6aa3563dece1f4ef&encoded=0&v=paper_preview&mkt=zh-cn
|
| [7] |
Menon S, Yecies JL, Zhang HH, et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice[J].Sci Signal, 2012, 5(217): ra24.
|
| [7] |
Menon S, Yecies JL, Zhang HH, et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice[J].Sci Signal, 2012, 5(217): ra24. http://cn.bing.com/academic/profile?id=2d2eae2dc7cfd7d8e041bfa0e53a13fa&encoded=0&v=paper_preview&mkt=zh-cn
|
| [8] |
Milella M, Falcone I, Conciatori F, et al. PTEN: Multiple Functions in Human Malignant Tumors[J]. Front Oncol, 2015, 5: 24.
|
| [8] |
Milella M, Falcone I, Conciatori F, et al. PTEN: Multiple Functions in Human Malignant Tumors[J]. Front Oncol, 2015, 5: 24. http://cn.bing.com/academic/profile?id=a63ac845af05d756541cfce1beb3234a&encoded=0&v=paper_preview&mkt=zh-cn
|
| [9] |
Ocana A, Vera-Badillo F, Al-Mubarak M, et al. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis[J]. PLoS One, 2014, 9(4): e95219. doi: 10.1371/journal.pone.0095219
|
| [9] |
Ocana A, Vera-Badillo F, Al-Mubarak M, et al. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis[J]. PLoS One, 2014, 9(4): e95219.
|
| [10] |
Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer[J].World J Gastroenterol, 2010, 16(37): 4627-33. doi: 10.3748/wjg.v16.i37.4627
|
| [10] |
Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer[J].World J Gastroenterol, 2010, 16(37): 4627-33.
|
| [11] |
Sendor AB, Hacker KE, Chen S, et al. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss[J].Gastrointest Cancer, 2015, 5: 61-71. http://cn.bing.com/academic/profile?id=dbae8b3a0e13eb577ec92d8b704cf357&encoded=0&v=paper_preview&mkt=zh-cn
|
| [11] |
Sendor AB, Hacker KE, Chen S, et al. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss[J]. Gastrointest Cancer, 2015, 5: 61-71.
|
| [12] |
Zhang FY, Hu Y, Que ZY, et al. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated beta-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine[J]. Int J Mol Sci, 2015, 16(10): 23823-48. doi: 10.3390/ijms161023823
|
| [12] |
Zhang FY, Hu Y, Que ZY, et al. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated beta-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine[J]. Int J Mol Sci, 2015, 16(10): 23823-48.
|
| [13] |
Chang L, Zhao D, Liu HB, et al. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma[J]. Mol Med Rep, 2015, 12(5): 6702-10.
|
| [13] |
Chang L, Zhao D, Liu HB, et al. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma[J]. Mol Med Rep, 2015, 12(5): 6702-10.
|
| [1] | CUI Honglei, ZHANG Xiaodan, GUO Danfeng, YAN Zhiping, GUO Wenzhi, ZHANG Shuijun. Expression of ENO3 and Its Effect on Sensitivity of Hepatocellular Carcinoma Cells to Oxaliplatin[J]. Cancer Research on Prevention and Treatment, 2022, 49(5): 438-443. DOI: 10.3971/j.issn.1000-8578.2022.21.1020 |
| [2] | ZHANG Xiufen, LIU Beibei, GUO Zijian, LI Lihua. UGCG is Involved in Oxaliplatin Resistance Mechanism of Human Colon Cancer Through Regulating MDR1/P-gp Expression[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 743-747. DOI: 10.3971/j.issn.1000-8578.2016.09.003 |
| [3] | XU Kai, CHENG Weiting, HU Zuowei, WANG Shan. Tanshinone ⅡA Inhibits Nerve Growth Factor Expression in Rats with Oxaliplatininduced Peripheral Neuropathy[J]. Cancer Research on Prevention and Treatment, 2015, 42(07): 648-651. DOI: 10.3971/j.issn.1000-8578.2015.07.002 |
| [4] | ZHU Yan, WU Gang, OUYANG Lichen, ZHU Fang, CHE Jing, ZHOU Yi. Effects of Monosialoganglioside-3 on Apoptosis and VEGF Expression in Human Cervical Cancer Cell Line HeLa[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 450-453. DOI: 10.3971/j.issn.1000-8578.2015.05.006 |
| [5] | SONG Min, MENG Yu, CHANG Zhiwei. Effects of Nav1.7 Expression on Neuropathic Pain Induced by Oxaliplatin[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 971-975. DOI: 10.3971/j.issn.1000-8578.2014.09.004 |
| [6] | ZHU Yiping, SHENG Lili, WANG Lu, JI Zhaoning. Clinical Efficacy of Oxaliplatin Combined with Capecitabine(XELOX) and Oxaliplatin Combined with S-1 (SOX) on Advanced Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 815-819. DOI: 10.3971/j.issn.1000-8578.2014.07.028 |
| [7] | QU Yanli, TANG Xushan, TANG Yong. Clinical Observation of S-1 Combined with Oxaliplatin or Paclitaxel on Advanced Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 811-814. DOI: 10.3971/j.issn.1000-8578.2014.07.027 |
| [8] | YANG Lin, SONG Yan, QIN Qiong, DUAN Huijie, DONG Qian, ZHONG Xiaomin, ZHOU Aiping, HUANG Jing, WANG Jinwan. Efficacy and Safety of S-1 Combined with Oxaliplatin as First Line Chemotherapy in Patients with Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(07): 688-692. DOI: 10.3971/j.issn.1000-8578.2013.07.013 |
| [9] | SONG Min, MENG Yu, REN Xiuhua, CHANG Zhiwei, CHANG Jie, LI Lei. Effects and Mechanism of Venlafaxine on Neuropathic Pain Induced by Oxaliplatin[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 555-559. DOI: 10.3971/j.issn.1000-8578.2013.06.012 |
| [10] | Zhao Yanxia, Cheng Jing, Zhu Fang, Wu Hongge, Chen Sheng. Study on Methylcobalamin in Preventing Docetaxel Chemotherapy-induced Peripheral Neurotoxicity in Patients with Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(12): 1487-1490. DOI: 10.3971/j.issn.1000-8578.2012.12.019 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: